Lck Inhibitor is a cell-permeable pyrrolopyrimidine compound that acts as a potent, selective, and ATP-competitive inhibitor of Lck (IC|50|at 5 μM ATP = < 1 nM, 2 nM, 70 nM, 1.57 μM and 1.98 μM for lck|64-509|Y|39|4, Lckcd pY394, Src, Kdr and Tie-2, respectively; IC|50|at 1 mM ATP = 16 μM, 66 nM, 126 nM, 420 nM and 5.18 μM for Lck64-509 Y394, Blk, Fyn, Lyn and Csk, respectively). Only minimally affects the activities of other kinases (IC|50|= 3.2 μM, > 33 μM, > 50 μM and > 50 μM for EGFR, PKC, CDC2/B and ZAP-70, respectively). Also shown to potently block T-cell receptor-stimulated IL-2 production in vitro (IC50 < 1-40 nM in Jurkat T cells).
Specifications and Purity: 10mM in DMSO
Molecular Formula: C23H22N4O
Molecular Weight: 370.45
PubChem CID: 6603792
Isomeric SMILES: C1CCC(C1)N2C=C(C3=C(N=CN=C32)N)C4=CC=C(C=C4)OC5=CC=CC=C5
- UPC:
- 51172111
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- L422581-1ml
- CAS:
- 213743-31-8
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





